Enrichment and Liquid Chromatography–Mass Spectrometry Analysis of Trastuzumab and Pertuzumab Using Affimer Reagents
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024
Project: A4B
Updated at: 28-04-2024